Abstract
Our research group has shown that a population of muscle-derived stem cells (MDSCs) isolated by a modified preplate technique from murine postnatal skeletal muscle displays a high transplantation capacity in both skeletal and cardiac muscles. The ability of MDSCs to proliferate in vivo for an extended period of time, combined with their strong capacity for self-renewal, resistance to stress, ability to undergo multilineage differentiation, ability to induce neovascularization and the paracrine effects that they have on the host, at least partially explains the high regenerative capacity of these cells in vivo. Although the true origin of MDSCs is unclear, the similarity to human blood vessel–derived stem cells suggests a putative origin from the vascular wall. This chapter reviews current knowledge on the utility of the MDSCs to improve the healing of various musculoskeletal tissues and injured cardiac muscle and lists the potential clinical applications based on this knowledge. We propose that these cells are a successful model for the use in regenerative medicine but emphasize that other factors, such as age and sex of the host and donor cells, should be considered.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aejaz, H., Aleem, N., Parveen, M., et al. (2007) Stem cell therapy: present status. Transplant Proc. 39, 694–9.
Amabile, G. and Meissner, A. (2009) Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med. 15, 59–68.
Gussoni, E., Soneoka, Y., Strickland, C.D., et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401, 390–4.
Partridge, T. (2000) The current status of myoblast transfer. Neurol Sci. 21, S939–42.
Peault, B., Rudnicki, M., Torrente, Y., et al. (2007) Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther. 15, 867–77.
Deasy, B.M., Li, Y., and Huard, J. (2004) Tissue engineering with muscle-derived stem cells. Curr Opin Biotechnol. 15, 419–23.
Tajbakhsh, S. (2009) Skeletal muscle stem cells in developmental versus regenerative myogenesis. J Intern Med. 266, 372–89.
Qu-Petersen, Z., Deasy, B., Jankowski, R., et al. (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol. 157, 851–64.
Lee, J.Y., Qu-Petersen, Z., Cao, B., et al. (2000) Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol. 150, 1085–100.
Gharaibeh, B., Lu, A., Tebbets, J., et al. (2008) Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc. 3, 1501–9.
Deasy, B., Gharaibeh, B., Pollett, J., et al. (2005) Long-term self-renewal of postnatal muscle-derived stem cells. Mol Cell Biol. 16, 3323–33.
Carr, L., Steele, D., Steele, S., et al. (2008) 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 19, 881–3.
Huard, J., Cao, B., and Qu-Petersen, Z. (2003) Muscle-derived stem cells: potential for muscle regeneration. Birth Defects Res C Embryo Today. 69, 230–7.
Deasy, B.M. and Huard, J. (2002) Gene therapy and tissue engineering based on muscle-derived stem cells. Curr Opin Mol Ther. 4, 382–9.
Jankowski, R.J., Deasy, B.M., and Huard, J. (2002) Muscle-derived stem cells. Gene Ther. 9, 642–7.
Mauro, A. (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 9, 493–5.
Asakura, A., Seale, P., Girgis-Gabardo, A., et al. (2002) Myogenic specification of side population cells in skeletal muscle. J Cell Biol. 159, 123–34.
Zheng, B., Cao, B., Crisan, M., et al. (2007) Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol. 25, 1025–34.
Tavian, M., Zheng, B., Oberlin, E., et al. (2005) The vascular wall as a source of stem cells. Ann N Y Acad Sci. 1044, 41–50.
Crisan, M., Yap, S., Casteilla, L., et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 3, 301–13.
Okada, M., Payne, T.R., Zheng, B., et al. (2008) Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol. 52, 1869–80.
Oshima, H., Payne, T., Urish, K., et al. (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther. 12, 1130–41.
Payne, T., Oshima, H., Okada, M., et al. (2007) A relationship between VEGF, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol. 50, 1677–84.
Deasy, B., Feduska, J., Payne, T., et al. (2009) Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther. 17, 1788–98.
Cao, B., Zheng, B., Jankowski, R.J., et al. (2003) Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol. 5, 640–6.
Payne, T., Oshima, H., Sakai, T., et al. (2005) Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther. 12, 1264–74.
Tang, Y.L., Zhao, Q., Qin, X., et al. (2005) Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg. 80, 229–36; discussion 236–7.
Corsi, K., Pollett, J., Phillippi, J., et al. (2007) Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res. 22, 1592–602.
Peng, H., Wright, V., Usas, A., et al. (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 110, 751–759.
Lavasani, M., Lu, A., Peng, H., et al. (2006) Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle. Hum Gene Ther. 17, 180–92.
Lavasani, M., Lu, A., Usas, A., et al. (2008) Human muscle-derived progenitor cells express neuronal and glial markers in vitro and promote peripheral nerve repair. Orthopaedic Research Society. Abstract 1625. March 2–5, San Francisco, CA.
Peng, H. and Huard, J. (2004) Muscle-derived stem cells for musculoskeletal tissue regeneration and repair. Transpl Immunol. 12, 311–9.
Lee, J.Y., Musgrave, D., Pelinkovic, D., et al. (2001) Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am. 83-A, 1032–9.
Shen, H.C., Peng, H., Usas, A., et al. (2004) Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone. 34, 982–92.
Peng, H., Usas, A., Gearhart, B., et al. (2004) Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther. 9, 885–94.
Shen, H., Peng, H., Usas, A., et al. (2004) Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med. 6, 984–91.
Peng, H., Usas, A., Hannallah, D., et al. (2005) Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther. 12, 239–46.
Hannallah, D., Peng, H., Young, B., et al. (2004) Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am. 86-A, 80–91.
Lehto, M., Duance, V., and Restall, D. (1985) Collagen and fibronectin in a healing skeletal muscle injury. J Bone Joint Surg Br. 67, 820–8.
Zhu, J., Li, Y., Shen, W., et al. (2007) Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem. 282, 25852–63
Li, Y., Li, J., Zhu, J., et al. (2007) Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther. 15, 1616–22.
Nozaki, M., Li, Y., Zhu, J., et al. (2008) Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med. 36, 2354–62.
Bosch, P., Musgrave, D., Ghivizzani, S., et al. (2000) The efficiency of muscle-derived cell-mediated bone formation. Cell Transplant. 9, 463–70.
Matsumoto, T., Cooper, G.M., Gharaibeh, B., et al. (2009) Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum. 60, 1390–405.
Boyle, A., Schulman, S., Hare, J., et al. (2006) Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation. 114, 339–52.
Fujii, T., Yau, T., Weisel, R., et al. (2003) Cell transplantation to prevent heart failure: a comparison of cell types. Ann Thorac Surg. 76, 2062–70.
Urish, K., Vella, J., Okada, M., et al. (2008) Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell. 20, 509–20.
Uemura, R., Xu, M., Ahmad, N., et al. (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 98, 1414–21.
Jain, M., DerSimonian, H., Brenner, D., et al. (2001) Cell Therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 103, 1920–7.
Murry, C., Reinecke, H., and Pabon, L. (2006) Regeneration gap observations on stem cells and cardiac repair. J Am Coll Cardiol. 47, 1777–85.
Carlson, M. and Conboy, I. (2007) Loss of stem cell regenerative capacity within aged niches. Aging Cell. 6, 371–82.
Collins, C., Zammit, P., Ruiz, A., et al. (2007) A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells. 25, 885–94.
Shefer, G., Mark, D.V.d., Richardson, J., et al. (2006) Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev Biol. 294, 50–66.
Gopinath, S.D. and Rando, T.A. (2008) Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell. 7, 590–8.
Deasy, B., Lu, A., Tebbets, J., et al. (2007) A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol. 177, 73–86.
Matsumoto, T., Kubo, S., Meszaros, L.B., et al. (2008) The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum. 58, 3809–19.
Crisostomo, P., Markel, T.A., Wang, M., et al. (2007) In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery. 142, 215–21.
Drowley, L., Okada, M., Payne, T.R., et al. (2009) Sex of muscle stem cells does not influence potency for cardiac cell therapy. Cell Transplant. 18, 1137–46.
Dernbach, E., Urbich, C., Brandes, R., et al. (2004) Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood. 104, 3591–7.
He, T., Peterson, T., Homuhamedov, E., et al. (2004) Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol. 24, 2021–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gharaibeh, B., Drowley, L., Huard, J. (2011). Muscle-Derived Stem Cells: A Model for Stem Cell Therapy in Regenerative Medicine. In: Appasani, K., Appasani, R. (eds) Stem Cells & Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-860-7_34
Download citation
DOI: https://doi.org/10.1007/978-1-60761-860-7_34
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-859-1
Online ISBN: 978-1-60761-860-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)